Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. We are seeking a highly motivated PhD- or Master’s-level intern to support deployment, optimization, and validation of the FACETS pipeline.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern